Atlas Trials

Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®

Clinical trial NCT04027803 · COMPLETED

Trial details

NCT number
NCT04027803
Sponsor
Biocad
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2018-09-21
Primary completion
2019-04-07
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.